Učitavanje...
Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
Ranibizumab is a monoclonal antibody fragment that inhibits angiogenesis by inhibiting vascular endothelial growth factor A, used as a treatment for patients with wet aged-related macular degeneration (ARMD). Adverse effects from intravitreal Ranibizumab injections are well recognised. Macular hole...
Spremljeno u:
| Izdano u: | Open Ophthalmol J |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Open
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4763958/ https://ncbi.nlm.nih.gov/pubmed/26962382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874364101509010177 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|